2018 Neuropsychopharmacology Reviews: Cannabis and Cannabinoids: From Synapse to Society



Cannabis and Cannabinoids: From Synapse to Society FREE

Margaret Haney and Matthew N Hill

Neuropsychopharmacology 43: 1-3; doi:10.1038/npp.2017.255


Review Articles

CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity Open

Arnau Busquets-Garcia, Jaideep Bains and Giovanni Marsicano

Neuropsychopharmacology 43: 4-20; advance online publication, October 18, 2017; doi:10.1038/npp.2017.206

The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development FREE

Heidi C Meyer, Francis S Lee and Dylan G Gee

Neuropsychopharmacology 43: 21-33; advance online publication, August 2, 2017; doi:10.1038/npp.2017.143

Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective FREE

Ziva D Cooper and Rebecca M Craft

Neuropsychopharmacology 43: 34-51; advance online publication, August 16, 2017; doi:10.1038/npp.2017.140

The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain FREE

Giulia Donvito, Sara R Nass, Jenny L Wilkerson, Zachary A Curry, Lesley D Schurman, Steven G Kinsey and Aron H Lichtman

Neuropsychopharmacology 43: 52-79; advance online publication, November 8, 2017; doi:10.1038/npp.2017.204

Integrating Endocannabinoid Signaling and Cannabinoids into the Biology and Treatment of Posttraumatic Stress Disorder FREE

Matthew N Hill, Patrizia Campolongo, Rachel Yehuda and Sachin Patel

Neuropsychopharmacology 43: 80-102; advance online publication, August 23, 2017; doi:10.1038/npp.2017.162

Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling FREE

J M Wenzel and J F Cheer

Neuropsychopharmacology 43: 103-115; advance online publication, August 9, 2017; doi:10.1038/npp.2017.126

Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure FREE

Leigh V Panlilio and Zuzana Justinova

Neuropsychopharmacology 43: 116-141; advance online publication, November 8, 2017; doi:10.1038/npp.2017.193

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol FREE

Douglas L Boggs, Jacques D Nguyen, Daralyn Morgenson, Michael A Taffe and Mohini Ranganathan

Neuropsychopharmacology 43: 142-154; advance online publication, October 18, 2017; doi:10.1038/npp.2017.209

Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? FREE

Cecilia J Hillard

Neuropsychopharmacology 43: 155-172; advance online publication, July 26, 2017; doi:10.1038/npp.2017.130

The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal FREE

Christina A Brezing and Frances R Levin

Neuropsychopharmacology 43: 173-194; advance online publication, October 18, 2017; doi:10.1038/npp.2017.212

US Epidemiology of Cannabis Use and Associated Problems Open

Deborah S Hasin

Neuropsychopharmacology 43: 195-212; advance online publication, November 8, 2017; doi:10.1038/npp.2017.198


Hot Topics

Toward a Translationally Relevant Preclinical Model of Cannabis Use FREE

Ryan J McLaughlin

Neuropsychopharmacology 43: 213; doi:10.1038/npp.2017.191

Setting the Legal Age for Access to Cannabis in Canada: Bridging Neuroscience, Policy, and Prevention FREE

Rebecca J Haines-Saah and Emily K Jenkins

Neuropsychopharmacology 43: 213-214; doi:10.1038/npp.2017.234

Medical Cannabis Research: Issues and Priorities FREE

Mark A Ware

Neuropsychopharmacology 43: 214-215; doi:10.1038/npp.2017.222

Selective Adenylyl Cyclase Type 1 Inhibitors as Potential Opioid Alternatives For Chronic Pain FREE

Val J Watts

Neuropsychopharmacology 43: 215-216; doi:10.1038/npp.2017.190

Novel Synthetic Opioids and Overdose Deaths: Tip of the Iceberg? FREE

Michael H Baumann and Gavril W Pasternak

Neuropsychopharmacology 43: 216-217; doi:10.1038/npp.2017.211

Opioidergic regulation of pain and pleasure in human social relationships FREE

Lauri Nummenmaa and Tomi Karjalainen

Neuropsychopharmacology 43: 217-218; doi:10.1038/npp.2017.200

Modulating Amygdala–Hippocampal Network Communication: A Potential Therapy for Neuropsychiatric Disorders FREE

Jie Zheng and Jack J Lin

Neuropsychopharmacology 43: 218-219; doi:10.1038/npp.2017.201

Modeling Non-Syndromic Autism with Human-Induced Pluripotent Stem Cells FREE

Luke AD Bury and Anthony Wynshaw-Boris

Neuropsychopharmacology 43: 219-220; doi:10.1038/npp.2017.195

Innovative Therapeutic Intervention For Opioid Use Disorder FREE

F Gerard Moeller and Kathryn A Cunningham

Neuropsychopharmacology 43: 220-221; doi:10.1038/npp.2017.192

The Ketamine Metabolite 2R,6R-Hydroxynorketamine Blocks NMDA Receptors and Impacts Downstream Signaling Linked to Antidepressant Effects FREE

Ege T Kavalali and Lisa M Monteggia

Neuropsychopharmacology 43: 221-222; doi:10.1038/npp.2017.210

Cognitive Signaling in Cerebellar Granule Cells FREE

Mark J Wagner

Neuropsychopharmacology 43: 222-223; doi:10.1038/npp.2017.186

The Promise of Genome Editing for Modeling Psychiatric Disorders FREE

Stephanie PB Caligiuri and Paul J Kenny

Neuropsychopharmacology 43: 223-224; doi:10.1038/npp.2017.197

Aggression Addiction and Relapse: A New Frontier in Psychiatry FREE

Sam A Golden and Yavin Shaham

Neuropsychopharmacology 43: 224-225; doi:10.1038/npp.2017.173

Computational Approaches to Behavior Analysis in Psychiatry FREE

Cheryl M Corcoran and Guillermo A Cecchi

Neuropsychopharmacology 43: 225-226; doi:10.1038/npp.2017.188

Cannabinoid Receptor 1 Positive Allosteric Modulators for Posttraumatic Stress Disorder FREE

Anantha Shekhar and Ganesh A Thakur

Neuropsychopharmacology 43: 226-227; doi:10.1038/npp.2017.230

Integrating ‘Omics’ Approaches to Prioritize New Pathogenetic Mechanisms for Mental Disorders Open

Annamaria Cattaneo and Carmine M Pariante

Neuropsychopharmacology 43: 227-228; doi:10.1038/npp.2017.221

A Translational Model to Assess Sign-Tracking and Goal-Tracking Behavior in Children FREE

Michelle A Joyner, Ashley N Gearhardt and Shelly B Flagel

Neuropsychopharmacology 43: 228-229; doi:10.1038/npp.2017.196

The Role of Mitochondrial Glutamate Metabolism in Cognitive Development and Disease FREE

Ozan Baytaş and Eric M Morrow

Neuropsychopharmacology 43: 229-230; doi:10.1038/npp.2017.202

Cross-Species Neurophysiological Biomarkers of Attentional Dysfunction in Schizophrenia: Bridging the Translational Gap FREE

Jared W Young and Gregory A Light

Neuropsychopharmacology 43: 230-231; doi:10.1038/npp.2017.218

Main navigation

ACNP resources

NPG resources

Extra navigation

17 November 2019